Cannabis Life Sciences CLSH Stock , announced today its financial and operational results for November 2020, for all its subsidiaries in Nevada, and boy was it great news! Net revenues of over $1.5 Million couple with a healthy 54.3% gross margin, the stock price jumped on the announcement today and kept climbing up as of the time of publishing this article. And for those of you unaware of the challenges facing Nevada, since the pandemic hit, Nevada has been one of the strictest places when it came to quarantines and restrictions, which makes one wonder what the earnings would be like same time next year under normal conditions?!
Quick Summary of Report November 2020 (Nevada Operations only) For CLSH Stock
- CLSH Stock Net revenue increased by 38.9% year to date, and Gross Margins increased by 8.1% during the same time period. Whats even more amazing is when compared to November 2018 this is a 112% increase in net reveunes.
- Wholly Owned Neveda Subsudary Oasis Cannabis saw a 47.1% increase during the same period, from $37.35 to $54.93 same time last year.
- Oasis Cannabis also had its biggest Black Friday sales to date, with a 22% increase compared to last year
Continued Strength in a Limited Market
In other news, City Tress, CLSH Stock wholesale division, City Trees, announced a new limited edition concentrate product in partnership with popular cultivator, State Flower. Social media is already buzzing after announcment and its expected that sales for the new product could hit record highs.
“Our achievements in November wouldn’t have been possible without the dedication and great work of all members of our team,” said company president and COO Andrew Glashow. “We also operated one less day in November to allow our team to enjoy the Thanksgiving holiday with their families. We’re looking forward to a strong finish to 2020.”
Industry analysts at BDS Analytics stated that CLSH Stock surpassed statewide industry growth by a large margin, this growth comes from a carefully planned strategy by CLSH Stock to expand its market share amdist strict restrictions by Neveda .
another article : 5 Reasons why OTC: SSET is a rising star in 2021